Genomics, Artificial Intelligence, Biology, Pharmaceutical, Cancer.
coactivators like p300/CBP and corepressors such as HDACs, unveiling their differential genomic occupancy in tumor versus normal cells. Cognit’s LGM executes in-silico simulations to predict the global impact of these epigenetic changes, identifying potential vulnerabilities and informing the